id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2023-D-3740-0005,FDA,FDA-2023-D-3740,Priority Zoonotic Animal Drug Designation and Review Process; Guidance for Industry; Availability,Notice,Notice of Availability,2024-06-26T04:00:00Z,2024,6,2024-06-26T04:00:00Z,,2024-06-26T13:21:43Z,2024-13921,0,0,09000064865c9e6f
FDA-2023-D-3740-0006,FDA,FDA-2023-D-3740,Priority Zoonotic Animal Drug Designation and Review Process; Guidance for Industry,Other,Guidance,2024-06-26T04:00:00Z,2024,6,2024-06-26T04:00:00Z,,2026-01-24T12:51:37Z,,1,0,09000064865ca00e
FDA-2023-D-3740-0002,FDA,FDA-2023-D-3740,Priority Zoonotic Animal Drug Designation and Review Process; Draft Guidance for Industry,Other,Guidance,2023-12-18T05:00:00Z,2023,12,2023-12-18T05:00:00Z,2024-02-17T04:59:59Z,2024-11-12T06:23:30Z,,1,0,0900006486343b8e
FDA-2023-D-3740-0001,FDA,FDA-2023-D-3740,Priority Zoonotic Animal Drug Designation and Review Process; Draft Guidance for Industry; Availability,Notice,Notice of Availability,2023-12-18T05:00:00Z,2023,12,2023-12-18T05:00:00Z,,2023-12-18T14:17:53Z,2023-27655,0,0,0900006486343903